News

A meta-analysis of 190 studies and 2.8 million children pinpoints eczema, delayed allergens, and antibiotics as top food allergy risks.

In 38 late preterm/early-term dyads, breast milk composition shifted by week 8 while maternal gut stayed stable, and infant gut Bifidobacterium rose.

Lisa Swanson, MD, addresses the practical barriers pediatricians face when trying to refer a patient with AD.

Lisa Swanson, MD, lays out the current JAK inhibitor landscape for pediatric AD.

New approvals and emerging data are expanding nonsteroidal topical treatment options for several chronic pediatric skin conditions.

Adverse childhood experiences may affect pediatric skin disease risk and outcomes, but researchers say evidence remains limited.

Scholar Rock says apitegromab's SMA BLA stays on track for its September 30, 2026, PDUFA date after dropping one of 2 fill-finish sites.

Executive order seeks to trim routine childhood vaccines, split combination shots, and push parent-doctor decisions—sparking debate as measles surges.

Phase 3 SMART data support the safety of clesrovimab in infants and children at increased risk for severe RSV disease across 2 seasons.

A pediatric pain specialist says a dedicated procedure suite helps deliver faster, more individualized chronic pain care while restoring function.

Phase 3 SMART trial found clesrovimab was well tolerated in high-risk infants through 2 RSV seasons, with safety comparable to palivizumab.

A pediatric pain specialist says multidisciplinary care and family engagement are key to restoring function in children with chronic pain.

A collaborative mental health program increased pediatricians' diagnosis, follow-up, and treatment of anxiety and depression in primary care.

A pediatric pain specialist says multidisciplinary care and family engagement are key to restoring function in children with chronic pain.

FDA accepted Merck's sBLA extending ENFLONSIA (clesrovimab-cfor) to high-risk children under 2 in their second RSV season.

An interventional pain specialist says pediatricians can improve outcomes by recognizing chronic pain early and referring children before disability worsens.

A look back at the FDA approvals, regulatory decisions, and pipeline updates in the pediatric health care space from July 2026.

Find out the correct diagnosis of this 19-year-old boy with Down syndrome and progressive loss of communication.

Lisa Swanson, MD, acknowledges that the decision to refer a patient with AD to a dermatologist or allergist is highly individualized, shaped by each pediatric clinician's own comfort level with skin disease.

Lisa Swanson, MD, describes the framework she uses at follow-up visits to judge whether a topical steroid regimen is succeeding.

A look back at the latest clinical trial updates for the pediatric population during July 2026.

Can you guess the diagnosis?

Help families enjoy summer cookouts: reduce choking risks, follow safe temps, and encourage balanced eating without pressure or food battles.

This FAQ breaks down the AAP's updated pediatric drowning prevention policy, covering supervision, water competency, life jackets, and rescue.

A large prospective US cohort study found no evidence that neonatal medical male circumcision was associated with autism diagnosis or autism traits.

A systematic review found chronic pediatric skin disorders are consistently associated with psychological distress, reduced quality of life, and caregiver burden.

Lisa Swanson, MD, narrows in on severity assessment tools that are actually practical for a busy pediatrics office, as opposed to the more elaborate scales used in clinical trials.

A scaly patch on a baby's scalp could be cradle cap — or the first sign of a lifelong condition. Lisa Swanson, MD, walks through the exact clues that tell the two apart.